ROR1 and neoplasm: ROR1 expression was shown to be retained on 90%–95% of tumor cells after 22.0405.aF treatment, indicating that 22.0405.aF exposure does not significantly downregulate the percentage of ROR1-positive cells in these settings (Figure 5A).